Pacific Biosciences ($PACB) - 10 Biotech IPOs of 2010
IPO Amount: $200M
Date: October 27
Range: $15 to $17
Actual price: $16
Scoop: Pacific Biosciences made a name for itself by raising impressive rounds of venture capital to fund its and SMRT technology, which uses nanofabrication, biochemistry, molecular biology, surface chemistry and optics to enable real-time analysis of biomolecules. The company raised a total of $370 million in VC before it went public. The company sold 12.5 million shares for $16 each, pricing it in the middle of its targeted $15 to $17 range. It trades on NASDAQ under the ticker PACB.
Comments